Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
ChEMBL v34 compound record for TIRZEPATIDE (CHEMBL4297839): max_phase 4 (approved), first_approval 2022, parenteral, GIP receptor agonist, first-in-class, black-box warning flag
Medium was exchanged every 2 days with reducing supplement concentration gradually
I June 9, 2026 Return policy Shipping Policy 4.5 (28) (1) (4) (2) 21% off 29% off 6% off Exclusive offer available (151) (100) (53) (55) (32) (85) (39) (13) (31) (18) 15% off (7) (75) (5) 31% off 22% off 38% off (12) 33% off 4.6 (58) (34) (15) (11) 17% off 10% off 25% off (3) (2.1K) (4.4K) (320) (231) (48) (90) (23) (20) (10) (21) 4.3 (428.8K) 4.7 (228.2K) 4.7 (189.4K) 4.6 (12K) 4.9 (407.3K) 4.5 (179.8K) 4.5 (94.4K) 4.7 (174.1K) 4.4 (9.5K) 4.7 (151.6K)
Want to get a prescription for B12 injections
It is combined with arginine to improve oral bioavailability and resist breakdown by stomach acid
The addition of the palmitoyl group makes the peptide more attracted to fats
US$ 21.62
US$ 29.53
US$ 29.18
US$ 26.64
US$ 21.81
US$ 26.96
US$ 25.71
US$ 22.93
US$ 26.05
US$ 21.21
US$ 13668.75
Sold : Login>>
